CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −412 | $109.50 | $45K | 2,137,338 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,803 | $110.80 | $421K | 2,133,535 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,404 | $111.69 | $157K | 2,132,131 |
| 2024-03-13 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $112.44 | $22K | 2,131,931 |
| 2024-03-08 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −544 | $99.05 | $54K | 9,267 |
| 2024-03-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,138 | 9,811 | ||
| 2024-03-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,138 | 5,694 | ||
| 2024-03-04 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −117 | $94.34 | $11K | 8,673 |
| 2024-03-04 | Hoge Stephen President | Sale 10b5-1 | −309 | $94.34 | $29K | 1,516,241 |
| 2024-03-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +233 | 8,790 | ||
| 2024-03-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −233 | 1,861 | ||
| 2024-03-01 | Hoge Stephen President | Exercise or conversion 10b5-1 | +652 | 1,516,550 | ||
| 2024-03-01 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −652 | 5,213 | ||
| 2024-02-29 | Mock James M Chief Financial Officer | Sale 10b5-1 | −647 | $94.57 | $61K | 4,300 |
| 2024-02-29 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −670 | $94.57 | $63K | 8,557 |
| 2024-02-29 | Hoge Stephen President | Sale 10b5-1 | −2,388 | $94.57 | $226K | 1,515,898 |
| 2024-02-28 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,315 | 4,947 | ||
| 2024-02-28 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,315 | 3,945 | ||
| 2024-02-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,315 | 9,227 | ||
| 2024-02-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,315 | 3,945 |
Page 34 of 38 · 743 trades